Definitive Contract 75D30121C12279

Award Date 9/30/21
Potential Completion Date 9/29/22
Potential Value $1.5M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dallas, TX 75201, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $612,097.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Baylor College of Medicine, a private health sciences university located in Houston, Texas. The contract is for research services and has a period of performance through September 24, 2020. The contract is a time and materials pricing type and was not set aside for a specific business category. Baylor College of Medicine is known for its expertise in areas such as genomics,...
This is a $500,000.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Baylor College of Medicine, a private non-profit university located in Houston, Texas. The contract is for research and development services, with a period of performance through September 29, 2029. The contract does not have a set-aside designation, indicating Baylor College of Medicine's competitiveness in securing federal work. Baylor College of Medicine is a leading...
This is a delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Baylor College of Medicine, a private non-profit university in Houston, Texas. The $305,327 award is under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery contract, which supports biomedical research and clinical trials related to vaccine and treatment development. The award has a completion date of July 11, 2023 and a potential total value of...
This federal contract award is for a $3,900,915 delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine, a private university and non-profit organization located in Houston, Texas. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical trials for influenza and other infectious disease vaccines and treatments. The contract tasks Baylor College of Medicine with conducting a...
This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Baylor College of Medicine, a private non-profit university, to conduct a $211,090 study on Hurricane Harvey. The contract did not have a set-aside designation. The study was completed on July 14, 2020, approximately one year after the contract was awarded on July 15, 2019. Baylor College of Medicine is an experienced federal contractor, having...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $148,458.06 delivery order to Baylor College of Medicine to transfer active work from an existing contract, HHSN272200800002C, to the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract, HHSN27220130015I. This order is not set aside. As a prime contractor, Baylor College of Medicine, a private non-profit...
This is a $293,890.90 Firm Fixed Price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Baylor College of Medicine, a private nonprofit university in Houston, Texas. The contract has a completion date of September 29, 2018 and was awarded on September 30, 2017. Baylor College of Medicine, as a prime contractor, has provided a range of services to federal agencies including clinical trial management, data analysis, specimen...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $4.8 million definitive contract to Vanderbilt University Medical Center to conduct research titled "Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Disease in Adults." The prime contractor will lead a network of 16 academic medical centers as subcontractors to study the effectiveness of influenza vaccines in preventing critical illness. This award was...
This firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private non-profit university located in Houston, Texas. The $99,063.44 contract does not have a set-aside designation, indicating Baylor's strong competitive standing in securing federal work. The award supports Baylor's expertise in biomedical research...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Baylor College of Medicine, a private health sciences university in Houston, Texas. The $2,791,658.62 contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The contract requires Baylor to perform protocol...

Baylor Research Institute was awarded a $1,499,900 firm fixed price definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention to conduct research under Broad Agency Announcement Topic 9.2, which solicited proposals to assess the effectiveness of influenza and COVID-19 vaccines against laboratory-confirmed outpatient illness during the 2021-2022 season. As the prime contractor, Baylor Research Institute will leverage its expertise in public health research to provide medical research services related to vaccine effectiveness from its location in Dallas, Texas. No set-aside designation was used for this contract award made by the CDC to support its ongoing efforts to monitor and improve vaccine programs.

Generated 2/1/24, 10:32 AM